BIODESIX INC (BDSX)

US09075X1081 - Common Stock

1.45  -0.03 (-2.03%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
54.51M
19.64%
38.21M
-29.90%
49.087M
28.47%
72.144M
46.97%
94.095M
30.43%
115.74M
23.00%
EBITDA
YoY % growth
-37.76M
-88.52%
-46.91M
-24.23%
-37.97M
19.06%
-24.072M
36.60%
-9.639M
59.96%
-510K
94.71%
EBIT
YoY % growth
-40.94M
-78.54%
-50.51M
-23.38%
-41.298M
18.24%
-36.437M
11.77%
-25.807M
29.18%
-18.224M
29.38%
Operating Margin
-75.11%-132.19%-84.13%-50.51%-27.43%-15.75%
EPS
YoY % growth
-1.54
-18.88%
-1.59
-3.25%
-0.65
59.12%
-0.36
45.34%
-0.22
37.80%
-0.15
30.77%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.07
30.30%
-0.07
49.00%
-0.06
26.05%
-0.05
24.23%
-0.05
32.68%
Revenue
Q2Q % growth
20.232M
37.93%
20.541M
38.62%
22.768M
27.02%
23.884M
31.59%
25.575M
26.41%
EBITDA
Q2Q % growth
-5.508M
-56.57%
-4.284M
55.06%
-4.182M
21.66%
-3.162M
25.90%
-2.244M
59.26%
EBIT
Q2Q % growth
-8.078M
-18.00%
-9.18M
16.19%
-6.902M
15.52%
-6.63M
22.83%
-6.12M
24.24%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.07
50.00%
-0.070.006.41%
Q2 2024
Q2Q % growth
-0.08
52.94%
-0.090.0114.75%
Q1 2024
Q2Q % growth
-0.14
41.67%
-0.150.014.24%
Q4 2023
Q2Q % growth
-0.10
71.43%
-0.110.0110.87%
Q3 2023
Q2Q % growth
-0.14
58.82%
-0.150.018.50%
Q2 2023
Q2Q % growth
-0.17
57.50%
-0.210.0419.36%
Q1 2023
Q2Q % growth
-0.24
52.00%
-0.240.000.58%
Q4 2022
Q2Q % growth
-0.35
28.57%
-0.28-0.07-23.65%
Q3 2022
Q2Q % growth
-0.34
17.07%
-0.33-0.01-1.78%
Q2 2022
Q2Q % growth
-0.40
2.44%
-0.470.0715.67%
Q1 2022
Q2Q % growth
-0.50
-117.39%
-0.41-0.09-21.54%
Q4 2021
Q2Q % growth
-0.49
-96.00%
-0.500.011.96%
Q3 2021
Q2Q % growth
-0.41
98.72%
-0.490.0815.82%
Q2 2021
Q2Q % growth
-0.41 -0.29-0.12-40.22%
Q1 2021
Q2Q % growth
-0.23 -0.18-0.05-28.85%
Q4 2020
Q2Q % growth
-0.25 -0.450.2044.30%
Q3 2020
Q2Q % growth
-31.93 -6.92-25.01-361.37%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
18.151M
34.54%
18.984M-833K-4.39%
Q2 2024
Q2Q % growth
17.925M
50.99%
16.538M1.387M8.39%
Q1 2024
Q2Q % growth
14.818M
63.63%
14.464M354K2.45%
Q4 2023
Q2Q % growth
14.668M
52.63%
15.919M-1.251M-7.86%
Q3 2023
Q2Q % growth
13.491M
21.43%
14.647M-1.156M-7.89%
Q2 2023
Q2Q % growth
11.872M
8.42%
11.905M-33K-0.28%
Q1 2023
Q2Q % growth
9.056M
38.26%
8.891M165K1.86%
Q4 2022
Q2Q % growth
9.61M
33.10%
10.987M-1.377M-12.53%
Q3 2022
Q2Q % growth
11.11M
70.14%
10.37M740K7.14%
Q2 2022
Q2Q % growth
10.95M
-7.91%
8.995M1.955M21.73%
Q1 2022
Q2Q % growth
6.55M
-77.31%
6.596M-46K-0.70%
Q4 2021
Q2Q % growth
7.22M
-73.29%
7.684M-464K-6.04%
Q3 2021
Q2Q % growth
6.53M
-28.94%
6.298M232K3.68%
Q2 2021
Q2Q % growth
11.89M
27.37%
21.565M-9.675M-44.86%
Q1 2021
Q2Q % growth
28.87M 26.774M2.096M7.83%
Q4 2020
Q2Q % growth
27.03M
10.09%
15.761M11.269M71.50%
Q3 2020
Q2Q % growth
9.19M 8.63M560K6.49%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 5.75% 0% -0.09%
Revenue0% 7.42% 0% -0.74%